Last week, Eli Lilly (LLY) announced that it would buy a development-stage psychedelics biopharma, AtaiBeckley, for roughly $2.8 billion in cash now, and a potential $1 billion more if Atai meets development and regulatory milestones. It may sound like a big number, but it is a drop in the bucket Read more
The COVID crisis is first and foremost a healthcare crisis, although it is having deep economic effects. Predictably, in the market volatility caused by the pandemic, the healthcare sector has broadly outperformed; and within healthcare, biotechnology has performed even more strongly. Of course healthcare is a broad sector, comprising many Read more
When Too Much News Can Confuse 1. GDP grew by 2.4 percent in 2015 — ignore flawed data, including GDPNow. Fourth-quarter 2015 GDP growth for the U.S. was just revised up to 1.4 percent annualized from an initial reading of 0.7 percent. That brings growth for the year as a Read more
31225 La Baya Drive, Suite 214
Westlake Village, CA 91362
1 310 826-8600
Mon-Fri 6:30-4:30
